Background Eosinophilic airway inflammation in patients with chronic obstructive pulmonary
disease (COPD) is associated with exacerbations and responsivity to steroids, suggesting …

Background Type 2 biomarkers that predict both likelihood of future severe exacerbations
and response to mAb therapy in asthma would be useful clinically in identifying patients both …

Background Asthma is a heterogeneous condition where biomarkers may be of
considerable advantage in diagnosis and therapy monitoring. However, the changes in …

Only very few studies have investigated the influence of eosinophils on the functional
progression of COPD. We aimed at retrospectively analyzing the trend of pulmonary function …

Because asthma and COPD are both inflammatory chronic obstructive airway diseases,
there are several clinical expressions which can cause confusion, such as: eosinophilic …

Background—Eosinophilic airway inflammation in COPD is associated with exacerbations
and responsivity to steroids, suggesting potential shared mechanisms with eosinophilic …

Asthma is a common, heterogeneous condition where current treatment options are limited
to a 'one size fits all'approach. Biological therapies targeting specific components of the …

Background: Type-2 asthma is often related to atopy and is characterized by elevated type-2
biomarkers. However, less is known about the pathophysiology of non-type 2 asthma …

Aktuálne odporúčania pre liečbu chronickej obštrukčnej choroby pľúc (CHOCHP) sa v
otázke farmakologickej liečby začínajú orientovať cestou personalizovaného prístupu. Tento …

Klin Farmakol Farm: Klinicky relevantné otázky a aktuálne trendy vo farmakoterapii
chronickej obštrukčnej choroby pľúc Časť 2: Duálna, kombinačná alebo trojitá liečba …